How does Crestor lower cardiovascular risk for adults with elevated cholesterol levels?

Crestor (rosuvastatin) is a statin medication that lowers cardiovascular risk in adults with elevated cholesterol. It works by blocking an enzyme called HMG-CoA reductase, which the liver needs to make cholesterol. This reduces LDL ("bad") cholesterol and, in some people, lowers inflammation. The FDA has approved Crestor to reduce the risk of major cardiovascular events like heart attack, stroke, and procedures to open blocked arteries in adults without existing heart disease but who have certain risk factors ¹.

What the research says

The FDA approval for Crestor's cardiovascular risk reduction is based on evidence showing it lowers LDL cholesterol and slows the buildup of plaque in arteries ¹. In a real-world study of Egyptian patients at very high risk of cardiovascular disease, a combination of Crestor (rosuvastatin 40 mg) and ezetimibe reduced LDL cholesterol by an average of 73% after 12 weeks, with 81% of patients reaching the recommended LDL target ¹¹. This highlights Crestor's potency when used alone or with other medications.

Crestor also reduces inflammation, measured by high-sensitivity C-reactive protein (hsCRP). The FDA indication includes adults with hsCRP ≥2 mg/L and at least one additional risk factor, even if their LDL is not very high ¹. Lowering inflammation is another way Crestor protects the heart.

However, like all statins, Crestor can cause side effects. A case report described a 63-year-old woman who developed rhabdomyolysis (severe muscle breakdown) after taking rosuvastatin 40 mg daily for a year ¹⁰. This is rare but serious, and doctors monitor for muscle pain or weakness. Another case report showed that a patient with familial hypercholesterolemia who had allergic reactions to statins was successfully desensitized to rosuvastatin, allowing her to tolerate it long-term ⁹. These cases underscore the importance of medical supervision.

In a large study comparing different lipid-lowering drugs, patients starting a PCSK9 inhibitor (another type of cholesterol drug) had a lower risk of developing depression than those starting a statin ⁷. This does not mean statins cause depression, but it suggests that mood effects may differ between drug classes and should be discussed with a doctor.

What to ask your doctor

• What is my target LDL cholesterol level, and how does Crestor help me reach it?
• How does Crestor compare with other statins or non-statin medications for my specific risk profile?
• What are the signs of muscle problems or other side effects I should watch for while taking Crestor?
• Should I have my hsCRP level checked to see if Crestor might reduce my inflammation-related risk?
• If I have trouble tolerating Crestor, are there alternative treatments or desensitization options available?